Activist pushes Acorda to sell, figuring pipeline's too risky to offset Ampyra loss
admin 7th August 2017 Uncategorised 0Acorda Therapeutics has an activist problem on its hands. After a key patent loss and company cutbacks, the hedge fund Scopia Capital Management is pushing Acorda to put itself on the block.
More: Activist pushes Acorda to sell, figuring pipeline's too risky to offset Ampyra loss
Source: fierce